Searched for
UMANG VOHRA
Cipla Q4 net profit slumps 55% YoY to Rs 555 crore, full-year PAT down 26%Pharma major Cipla announced a significant 55% drop in its net profit for the March quarter. Total income also saw a 3% decrease. For the f...- Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4Cohance Lifesciences shares dropped significantly after reporting an 84% year-on-year decline in March-quarter net profit. Jefferies downgr...
- Cohance Lifesciences shares rocket 43% in just 2 trading sessions. Here’s what is fuelling the surgeCohance Lifesciences shares surged over 43% in two days following the appointment of former Cipla CEO Umang Vohra as Executive Chairman and...
- Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang VohraShares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and...
- Cipla global CEO Umang Vohra to step down; Achin Gupta to take overCipla's global CEO Umang Vohra will step down in March 2026. Achin Gupta, currently global COO, will take over as the new MD and GCEO from ...
- Cipla expects record 24 per cent Ebitda margin in FY24"We enter reverse seasonalist in our India business. The fourth quarter has always been the lowest, so that impacts our margins," Umang Voh...
- Cipla invests Rs 42 crore in digital tech firm GoApptivCipla boosts investment in GoApptiv with Rs. 42 crore infusion, raising its stake to 22.99%. This marks their third investment in the digit...
- Reports of likely promoter stake sale making people anxious: Cipla MD Vohra"We're all human beings, we get distracted with what happens, because of this and that distraction creates difficulties for us in the way w...
- Cipla vows to crack diabetes segment with licensed branded portfolio"Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area," said Umang Vohra, managing d...
- Cipla sticks to 21-22% operating profit guidance for FY23, posts Rs 789 crore profit in Q2Cipla reported a multi-quarter high of $179 million in revenue and 25% YoY growth led by the successful launch of a generic version of the ...
- Cipla board approves reappointment of Umang Vohra as MD & Global CEO for 5 yearsThe board of directors has considered and approved the re-appointment of Umang Vohra, Managing Director, designated as 'Managing Director a...
- Cipla gets final approval from USFDA for Albuterol Sulfate Inhalation AerosolIn a regulatory filing the company said "it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfa...
- Cipla trying to create a healthcare ecosystem in India: Umang Vohra“We are happy with our Q1 numbers in a tough environment.”
- Cipla at the bottom end of margin in industry: Umang Vohra, MD & Global CEOFor the leverage to be more in the future, we need to have more unlocking in the US pipeline, which is what most analysts are also saying.
- Cipla more focused on saving lives in Africa: Umang Vohra, Global CEOIndia will continue to be the largest market for Cipla and we hope to cross the $1 billion mark in India relatively soon.
- Cipla names Samina Vaziralli as Executive Vice-ChairmanVaziralli, daughter of MK Hamied -- the company's non-executive VC - has been a part of the core leadership team since joining the Mumbai-b...
- Cipla hires Kedar Upadhye from Dr. Reddy's as global CFOCipla said in a June 8 announcement to stock exchanges, Kedar Upadhye will be joining the organization as its Global chief financial office...
- Cipla should launch 10 odd products in the FY17: Umang Vohra, Global COO"Cipla FY16 guidance of 20-22 per cent revenue growth and 100 to 150 bps margin improvement for this year does not include InvaGen"
- Cipla Ltd ropes in Umang Vohra as Global Chief Financial and Strategy OfficerCipla Ltd today appointed former head of Dr Reddy's North American business Umang Vohra as its Global Chief Financial and Strategy Officer.
- Budget mildly positive for pharma industry: Umang Vohra, Dr. Reddy's LabsIt is a very neutral cum mildly positive budget and it is mildly positive because there is a lot of work that the government is doing.
Load More
